When making a differential diagnosis, a series of non-histiocytic tumors should also be considered, including systemic mastocytosis, malignant melanoma, and poorly differentiated carcinoma, all of which can be ruled out based on the characteristic morphological manifestations and negative immune expression patterns of CD1 and langerin. This evidence concerns the gene CD1A and systemic mastocytosis.